JSPR Aset Perusahaan Jasper Therapeutics

JSPR (jaspertherapeutics.com) - tandha merek perusahaan

The following quotes on the GURU.Markets platform for the aggregate assets of Jasper Therapeutics (JSPR) stand at 29.13. The business relies on the creation of transplantation antibodies, outsourcing the production of briquilimab to external partners to maximize profits. Management is implementing less aggressive stem cell transplant conditioning protocols. Stable leadership under Roland Martell ensures the flawless execution of all clinical trial stages.

JSPR - Total Aset Perusahaan Jasper Bio ing rentang 04.07.2022 - 30.10.2026

Rincian analitis lan laporan data perusahaan jaspertherapeutics.com (JSPR)

- rega saham lan target rega konsensus:
Bagan owah-owahan rega Jasper Therapeutics, Inc.|JSPR - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar JSPR|JSPR - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Ekuitas saben Saham Jasper Therapeutics|JSPR - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih jaspertherapeutics.com|JSPR - Aset Agregat Perusahaan
- rincian utang lan likuiditas:
Utang marang Modal Jasper Therapeutics|JSPR - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Jasper Therapeutics, Inc.|JSPR - Utang perusahaan|Utang-utang marang nilai buku JSPR|JSPR - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Jasper Therapeutics|Likuiditas darurat jaspertherapeutics.com
- statistik bathi lan rasio pasar:
JSPR - Penghasilan resik
Analisis dhasar perusahaan:JSPR Jasper Bio
Produk mawa merek Jasper Therapeutics, Inc.

The integration of AI models and automated bioscreening into the oncology drug discovery process at Jasper Therapeutics (JSPR) is reflected in the valuation of the company's financial assets, capturing the value of its technological foundation. This indicator, reverse-calculated via return on assets (ROA), measures the total volume of resources and liabilities, allowing investors to distinguish genuine capitalization growth from a dangerous balance sheet inflation amid a liquidity deficit.

Pesaing langsung

legendbiotech.com - Nilai Agregat Aset|Aset Agregat Perusahaan Sana Biotechnology, Inc.|Aset Perusahaan Autolus Therapeutics PLC AUTL|Aset Agregat Perusahaan Allogene Therapeutics Inc (ALLO)|Selecta Biosciences Inc. - Total Aset Bisnis|Total Aset Perusahaan CLLS (Cellectis)|CRBU - Gunggung Aset Perusahaan|TIL - Aset Agregat Perusahaan|Aset Perusahaan Genenta Science S.p.A.|centurytx.com (IPSC) - Aset Agregat Perusahaan|SNTI (Senti Biosciences) - Aset Agregat Perusahaan|Aset Agregat Perusahaan Adaptimmune Therapeutics plc|Aset Perusahaan CERo Therapeutics Holdings Inc. CERO|Total Aset Perusahaan TCRT|achillestx.com (ACHL) - Aset Neraca Perusahaan|Cargo Therapeutics - Gunggung Aset Perusahaan|Poseida Corp (PSTX) - Aset Perusahaan|TSVT: Gunggung Aset Perusahaan|Nilai Agregat Aset GRCL (gracellbio.com)